EP Patent

EP3735966A1 — Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound

Assigned to Evofem Inc · Expires 2020-11-11 · 6y expired

What this patent protects

The present disclosure relates to compositions and methods for inhibiting inflammation and reducing the risk of spreading sexually transmitted diseases using an alginic acid-based antimicrobial compound. Such compositions provide dual protection by (1) attacking and inactivating …

USPTO Abstract

The present disclosure relates to compositions and methods for inhibiting inflammation and reducing the risk of spreading sexually transmitted diseases using an alginic acid-based antimicrobial compound. Such compositions provide dual protection by (1) attacking and inactivating viruses and other microbes and (2) blocking the host response that viruses trigger to invade host cells. Such compositions can also be part of an acid buffering contraceptive.

Drugs covered by this patent

Patent Metadata

Patent number
EP3735966A1
Jurisdiction
EP
Classification
—
Expires
2020-11-11
Drug substance claim
No
Drug product claim
No
Assignee
Evofem Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.